��������

Mark Rosenblum is an experienced professional in the healthcare and finance sectors, currently serving as a Partner at Company Ventures since May 2023. Prior to this role, Rosenblum was the Managing Director of New Ventures at Redesign Health from February 2020 to May 2023, leading the launch of several healthcare companies. Rosenblum's extensive background includes positions as Vice President and Investment Analyst at Epoch Investment Partners, Inc., and Vice President in Healthcare Services Equity Research at Morgan Stanley, contributing to significant equity analysis and research in healthcare sectors. Earlier experience includes serving as an Investment Banking Associate at Jefferies LLC and a Portfolio Management Senior Associate at Epoch Investment Partners. Academic qualifications include an MBA from Duke University's Fuqua School of Business and a Bachelor of Science in Finance from the University of Maryland.